Phase II study of bevacizumab and erlotinib in treatment-naive elderly patients (older than age 65) with advanced non-small cell lung cancer (NSCLC).
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7548-7548
◽
Keyword(s):
Phase Ii
◽